Caroline Strasinger
FDA investigator
Appears on 1 document from 2019, mostly at sites in Japan. Most often cites testing and release for distribution (21 CFR 211.165).
- 1
- Documents on file
- 4.0
- Observations per 483
- 2019
- First seen
- 2019
- Most recent
What they cite most
From 4 observations- 21 CFR 211.165Testing and release for distribution2
- 21 CFR 211.192Production record review2
- 21 CFR 211.160General requirements1
- 21 CFR 211.194Laboratory records1
Activity by year
2019: 1
Where
Japan 1
Often inspects with
Is Caroline Strasinger coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2019-05-31 | 483 Hisamitsu Pharmaceutical Co., Inc.May 31, 2019 · Tosu, Japan | Tosu, Japan | 4 |
About this profile
What does Caroline Strasinger inspect?
Caroline Strasinger appears on 1 document on file covering 1 site, mostly in Japan.
What do they cite most often?
21 CFR 211.165 (testing and release for distribution), followed by 21 CFR 211.192 and 21 CFR 211.160.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Caroline Strasinger is dated May 31, 2019.